the limbic thelimbic.com

This January saw the roll out of the Medical Board of Australia’s updated CPD requirements – all registered doctors are now required to complete 50 hours of CPD annually – this includes preparing a professional development plan, and at least 25 hours spent on activities related to reviewing performance and measuring outcomes.

Now four months into the program, Chair of the Medical Board of Australia, Dr Anne Tonkin speaks to the limbic about the changes – why they were introduced, how the 50 hours are broken down, what the professional development plan looks like and her thoughts on how the changes will impact clinicians.

In this first of two episodes, we speak to two leading UK haematologists, Dr Robin Sanderson (King’s College London) and Dr Caroline Besley (Bristol), about the innovative way in which CAR-T was introduced in the UK, the challenges that have been overcome, including the impact of Covid-19, and what they have learnt so far about using this highly personalised therapy.

In this podcast senior researcher at the Westmead Institute for Medical Research, Dr Thomas Tu discusses the latest developments in hepatitis B presented at this year’s GESA scientific meeting - from new treatments under development that bring the promise of cure closer to public health viral elimination strategies.

And Dr Avik Majumdar, transplant hepatologist at the Royal Prince Alfred Hospital in Sydney shares his highlights from the Liver stream discussing new data identifying sub groups and prognosis in decompensated cirrhosis, new treatment developments in  primary sclerosing cholangitis and liver disease and the increasing role of non-invasive evaluation on prognosis in liver disease.

New FH guidance signal the shift into the era of genetic medicine for cardiologists according to specialists who foresee increased numbers of individuals being identified with heritable gene mutations from the recent publicly funded genetic testing.

The. updated Guidance released earlier this year covers updates in diagnosis and genetic testing , risk stratification, management and the latest evidence around new treatments.

In this episode lipid specialist Associate Professor David Sullivan and genetics counsellor Catherine Spinks discuss the details of the genetic test and how it fits into diagnosis and screening protocols. And paediatric cardiologist Dr Ari Horton joins us to discuss how the introduction of the MBS funded genetic test will provide the very real opportunity to expand the number of potential cases detected.

In this MOGA 21 highlights episode Dr Christina Teng, winner of this year's YOGA oral abstract prize, discusses her work looking into just how long chemotherapy induced peripheral neuropathy (CIPN) persists that provides some fascinating insights that could help clinicians discuss the side effect with patients.

We also speak to Dr Wei Hong, winner of this year's poster presentation, who discusses his latest work looking into a new approach to conducting oncology clinical trials that could save much needed time and money.